pubmed-article:19672264 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0206698 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0005423 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:19672264 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:19672264 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:19672264 | pubmed:dateCreated | 2009-8-12 | lld:pubmed |
pubmed-article:19672264 | pubmed:abstractText | We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients with locally advanced (LA) or metastatic (M) (advanced) biliary cancers (ABC) for whom there is no standard chemotherapy. | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:language | eng | lld:pubmed |
pubmed-article:19672264 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19672264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19672264 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19672264 | pubmed:month | Aug | lld:pubmed |
pubmed-article:19672264 | pubmed:issn | 1532-1827 | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:MeyerTT | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:EvansLL | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:JohnsonPP | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:JonesEE | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:SwindellRR | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:OsborneRR | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:DixonLL | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:FalkSS | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:MaraveyasAA | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:WasanHH | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:HighleyMM | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:IvesonTT | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:BridgewaterJJ | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:LoftsFF | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:AnthoneyAA | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:ValleJ WJW | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:CorriePP | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:BakaSS | lld:pubmed |
pubmed-article:19672264 | pubmed:author | pubmed-author:GollinsSS | lld:pubmed |
pubmed-article:19672264 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19672264 | pubmed:day | 18 | lld:pubmed |
pubmed-article:19672264 | pubmed:volume | 101 | lld:pubmed |
pubmed-article:19672264 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19672264 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19672264 | pubmed:pagination | 621-7 | lld:pubmed |
pubmed-article:19672264 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:meshHeading | pubmed-meshheading:19672264... | lld:pubmed |
pubmed-article:19672264 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19672264 | pubmed:articleTitle | Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. | lld:pubmed |
pubmed-article:19672264 | pubmed:affiliation | Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. juan.valle@christie.nhs.uk | lld:pubmed |
pubmed-article:19672264 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19672264 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19672264 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19672264 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:19672264 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19672264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19672264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19672264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19672264 | lld:pubmed |